US equities
|
INTC
$65.48
▼-28.88%
AMZN
$239.26
▼-1.86%
MU
$885.43
▼-5.23%
NVDA
$205.81
▼-3.67%
SNDK
$1,172.83
▼-11.82%
GOOGL
$282.15
▼-0.59%
SPCX
$138.29
▼-3.89%
AMD
$510.49
▼-9.87%
INTC
$65.48
▼-28.88%
AMZN
$239.26
▼-1.86%
MU
$885.43
▼-5.23%
NVDA
$205.81
▼-3.67%
SNDK
$1,172.83
▼-11.82%
GOOGL
$282.15
▼-0.59%
SPCX
$138.29
▼-3.89%
AMD
$510.49
▼-9.87%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about NASDAQ:ADAP
Recent news which mentions NASDAQ:ADAP
ADAP Stock Earnings: Adaptimmune Therapeutics Beats EPS, Beats Revenue for Q2 2024
August 12, 2024
Tickers
ADAP
Tags
NASDAQ:ADAP
Market News
Earnings Reports
From
InvestorPlace
ADAP Stock Earnings: Adaptimmune Therapeutics Misses EPS, Misses Revenue for Q1 2024
May 15, 2024
Tickers
ADAP
Tags
Earnings Reports
Market News
NASDAQ:ADAP
From
InvestorPlace
ADAP Stock Earnings: Adaptimmune Therapeutics Misses EPS, Misses Revenue for Q4 2023
March 06, 2024
Tickers
ADAP
Tags
NASDAQ:ADAP
Market News
ADAP
From
InvestorPlace